| Literature DB >> 34302744 |
Jolien Vandewalle1, Steven Timmermans1, Ville Paakinaho2, Lies Vancraeynest3, Liza Dewyse4, Tineke Vanderhaeghen1, Charlotte Wallaeys1, Lise Van Wyngene1, Kelly Van Looveren1, Louise Nuyttens1, Melanie Eggermont1, Sylviane Dewaele1, Tiago R Velho5, Luis F Moita5, Sebastian Weis6, Christoph Sponholz7, Leo A van Grunsven4, Mieke Dewerchin8, Peter Carmeliet9, Karolien De Bosscher10, Johan Van de Voorde3, Jorma J Palvimo2, Claude Libert11.
Abstract
Sepsis is a potentially lethal syndrome resulting from a maladaptive response to infection. Upon infection, glucocorticoids are produced as a part of the compensatory response to tolerate sepsis. This tolerance is, however, mitigated in sepsis due to a quickly induced glucocorticoid resistance at the level of the glucocorticoid receptor. Here, we show that defects in the glucocorticoid receptor signaling pathway aggravate sepsis pathophysiology by lowering lactate clearance and sensitizing mice to lactate-induced toxicity. The latter is exerted via an uncontrolled production of vascular endothelial growth factor, resulting in vascular leakage and collapse with severe hypotension, organ damage, and death, all being typical features of a lethal form of sepsis. In conclusion, sepsis leads to glucocorticoid receptor failure and hyperlactatemia, which collectively leads to a lethal vascular collapse.Entities:
Keywords: glucocorticoid resistance; hyperlactatemia; metabolism; sepsis; shock
Mesh:
Substances:
Year: 2021 PMID: 34302744 DOI: 10.1016/j.cmet.2021.07.002
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287